393 related articles for article (PubMed ID: 35506376)
21. Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.
Giuliano M; Herrera S; Christiny P; Shaw C; Creighton CJ; Mitchell T; Bhat R; Zhang X; Mao S; Dobrolecki LE; Al-rawi A; Chen F; Veneziani BM; Zhang XH; Hilsenbeck SG; Contreras A; Gutierrez C; Jeselsohn RM; Rimawi MF; Osborne CK; Lewis MT; Schiff R; Trivedi MV
Breast Cancer Res; 2015 Jan; 17(1):3. PubMed ID: 25572662
[TBL] [Abstract][Full Text] [Related]
22. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
[TBL] [Abstract][Full Text] [Related]
23. Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis.
Borin TF; Angara K; Rashid MH; Achyut BR; Arbab AS
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29292756
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous inhibition of breast cancer and its liver and lung metastasis by blocking inflammatory feed-forward loops.
Lu Z; Long Y; Li J; Li J; Ren K; Zhao W; Wang X; Xia C; Wang Y; Li M; Zhang Z; He Q
J Control Release; 2021 Oct; 338():662-679. PubMed ID: 34478751
[TBL] [Abstract][Full Text] [Related]
25. Separation of breast cancer and organ microenvironment transcriptomes in metastases.
Alzubi MA; Turner TH; Olex AL; Sohal SS; Tobin NP; Recio SG; Bergh J; Hatschek T; Parker JS; Sartorius CA; Perou CM; Dozmorov MG; Harrell JC
Breast Cancer Res; 2019 Mar; 21(1):36. PubMed ID: 30841919
[TBL] [Abstract][Full Text] [Related]
26. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression.
Stenström J; Hedenfalk I; Hagerling C
Breast Cancer Res; 2021 Feb; 23(1):27. PubMed ID: 33602289
[TBL] [Abstract][Full Text] [Related]
27. Cell-cell communication characteristics in breast cancer metastasis.
Xu J; Gao F; Liu W; Guan X
Cell Commun Signal; 2024 Jan; 22(1):55. PubMed ID: 38243240
[TBL] [Abstract][Full Text] [Related]
28. Understanding crosstalk of organ tropism, tumor microenvironment and noncoding RNAs in breast cancer metastasis.
Chakraborty S; Banerjee S
Mol Biol Rep; 2023 Nov; 50(11):9601-9623. PubMed ID: 37792172
[TBL] [Abstract][Full Text] [Related]
29. The role of RNA processing and regulation in metastatic dormancy.
Parker KA; Robinson NJ; Schiemann WP
Semin Cancer Biol; 2022 Jan; 78():23-34. PubMed ID: 33775829
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments.
Fluegen G; Avivar-Valderas A; Wang Y; Padgen MR; Williams JK; Nobre AR; Calvo V; Cheung JF; Bravo-Cordero JJ; Entenberg D; Castracane J; Verkhusha V; Keely PJ; Condeelis J; Aguirre-Ghiso JA
Nat Cell Biol; 2017 Feb; 19(2):120-132. PubMed ID: 28114271
[TBL] [Abstract][Full Text] [Related]
31. Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis.
Louie E; Chen XF; Coomes A; Ji K; Tsirka S; Chen EI
Oncogene; 2013 Aug; 32(35):4064-77. PubMed ID: 23001042
[TBL] [Abstract][Full Text] [Related]
32. Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets.
Liang Y; Zhang H; Song X; Yang Q
Semin Cancer Biol; 2020 Feb; 60():14-27. PubMed ID: 31421262
[TBL] [Abstract][Full Text] [Related]
33. JUNB suppresses distant metastasis by influencing the initial metastatic stage.
Wutschka J; Kast B; Sator-Schmitt M; Appak-Baskoy S; Hess J; Sinn HP; Angel P; Schorpp-Kistner M
Clin Exp Metastasis; 2021 Aug; 38(4):411-423. PubMed ID: 34282521
[TBL] [Abstract][Full Text] [Related]
34. Breast Cancer Metastasis: Mechanisms and Therapeutic Implications.
Park M; Kim D; Ko S; Kim A; Mo K; Yoon H
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743249
[TBL] [Abstract][Full Text] [Related]
35. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
36. Novel approaches to target the microenvironment of bone metastasis.
Hofbauer LC; Bozec A; Rauner M; Jakob F; Perner S; Pantel K
Nat Rev Clin Oncol; 2021 Aug; 18(8):488-505. PubMed ID: 33875860
[TBL] [Abstract][Full Text] [Related]
37. Biomimetic strategies to recapitulate organ specific microenvironments for studying breast cancer metastasis.
Narkhede AA; Shevde LA; Rao SS
Int J Cancer; 2017 Sep; 141(6):1091-1109. PubMed ID: 28439901
[TBL] [Abstract][Full Text] [Related]
38. Splenectomy reduces lung metastases and tumoral and metastatic niche inflammation.
Stöth M; Freire Valls A; Chen M; Hidding S; Knipper K; Shen Y; Klose J; Ulrich A; Ruiz de Almodovar C; Schneider M; Schmidt T
Int J Cancer; 2019 Nov; 145(9):2509-2520. PubMed ID: 31034094
[TBL] [Abstract][Full Text] [Related]
39. Cellular dormancy in minimal residual disease following targeted therapy.
Ruth JR; Pant DK; Pan TC; Seidel HE; Baksh SC; Keister BA; Singh R; Sterner CJ; Bakewell SJ; Moody SE; Belka GK; Chodosh LA
Breast Cancer Res; 2021 Jun; 23(1):63. PubMed ID: 34088357
[TBL] [Abstract][Full Text] [Related]
40. Bisphosphonates and their impact on disseminated tumor cells in early stage breast cancer.
Li J; Rugo HS
Breast Dis; 2011; 33(2):83-92. PubMed ID: 22142661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
